{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T20:02:16Z","timestamp":1785441736497,"version":"3.56.0"},"reference-count":79,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["anesthesiology.theclinics.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anesthesiology Clinics"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.anclin.2026.04.003","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T04:00:09Z","timestamp":1780632009000},"page":"433-451","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Anesthetic and Peripartum Management of Inherited Coagulation Disorders in Pregnancy"],"prefix":"10.1016","volume":"44","author":[{"given":"Talia","family":"Scott","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.anclin.2026.04.003_bib1","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1538-7836.2008.02921.x","article-title":"Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA study","volume":"6","author":"Pomp","year":"2008","journal-title":"J Thromb Haemostasis"},{"issue":"2","key":"10.1016\/j.anclin.2026.04.003_bib2","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1016\/j.jogc.2017.11.036","article-title":"No. 163-Gynaecological and obstetric management of women with inherited bleeding disorders","volume":"40","author":"Demers","year":"2018","journal-title":"J Obstet Gynaecol Can"},{"issue":"8","key":"10.1016\/j.anclin.2026.04.003_bib3","first-page":"e193","article-title":"On behalf of the Royal College of obstetricians and gynaecologists. Management of inherited bleeding Disorders in Pregnancy. Green-top Guideline No. 71","volume":"124","author":"Pavord","year":"2017","journal-title":"BJOG Int J Obstet Gynaecol"},{"issue":"7","key":"10.1016\/j.anclin.2026.04.003_bib4","doi-asserted-by":"crossref","first-page":"326","DOI":"10.5694\/mja2.50123","article-title":"Updated Australian consensus statement on management of inherited bleeding disorders in pregnancy","volume":"210","author":"Dunkley","year":"2019","journal-title":"Med J Aust"},{"key":"10.1016\/j.anclin.2026.04.003_bib5","author":"Sabih"},{"issue":"7","key":"10.1016\/j.anclin.2026.04.003_bib6","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1182\/blood-2007-11-122945","article-title":"A shorter von Willebrand factor survival in O blood group subjects explains how ABO determinants influence plasma von Willebrand factor","volume":"111","author":"Gallinaro","year":"2008","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.anclin.2026.04.003_bib7","first-page":"89","article-title":"Factor VIII and factor IX in a twin population. Evidence for a major effect of ABO locus on factor VIII level","volume":"37","author":"Orstavik","year":"1985","journal-title":"Am J Hum Genet"},{"issue":"3","key":"10.1016\/j.anclin.2026.04.003_bib8","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ajog.2010.02.036","article-title":"von Willebrand disease and pregnancy: a practical approach for the diagnosis and treatment","volume":"203","author":"Pacheco","year":"2010","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.anclin.2026.04.003_bib9","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1213\/ANE.0000000000005502","article-title":"Anesthetic Management of Von Willebrand Disease in Pregnancy: a Retrospective Analysis of a Large Case Series","volume":"133","author":"Reale","year":"2021","journal-title":"Anesth Analg"},{"issue":"1","key":"10.1016\/j.anclin.2026.04.003_bib10","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/hae.12568","article-title":"Postpartum von Willebrand factor levels in women with and without von Willebrand disease and implications for prophylaxis","volume":"21","author":"James","year":"2015","journal-title":"Haemophilia"},{"issue":"6","key":"10.1016\/j.anclin.2026.04.003_bib11","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1111\/j.1538-7836.2007.02563.x","article-title":"Bleeding events and other complications during pregnancy and childbirth in women with von Willebrand disease","volume":"5","author":"James","year":"2007","journal-title":"J Thromb Haemost"},{"issue":"10","key":"10.1016\/j.anclin.2026.04.003_bib12","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1080\/17474086.2016.1216312","article-title":"Present day management of inherited bleeding disorders in pregnancy","volume":"9","author":"Kouides","year":"2016","journal-title":"Expert Rev Hematol"},{"issue":"5","key":"10.1016\/j.anclin.2026.04.003_bib13","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1055\/s-0039-1700541","article-title":"Type 3 von Willebrand Disease in Pregnancy: a Systematic Literature Review","volume":"38","author":"Makhamreh","year":"2021","journal-title":"Am J Perinatol"},{"issue":"5","key":"10.1016\/j.anclin.2026.04.003_bib14","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1055\/s-0031-1281044","article-title":"Diagnosis and management of von Willebrand disease in a single institution of Argentina","volume":"37","author":"Woods","year":"2011","journal-title":"Semin Thromb Hemost"},{"issue":"1","key":"10.1016\/j.anclin.2026.04.003_bib15","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-2516.2011.02573.x","article-title":"A systematic review: the use of desmopressin for treatment and prophylaxis of bleeding disorders in pregnancy","volume":"18","author":"Trigg","year":"2012","journal-title":"Haemophilia"},{"key":"10.1016\/j.anclin.2026.04.003_bib16","doi-asserted-by":"crossref","first-page":"3382","DOI":"10.1182\/blood-2004-11-4472","article-title":"Use of desmopressin (DDAVP) during early pregnancy in factor VIII-deficient women","volume":"105","author":"Mannucci","year":"2005","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.anclin.2026.04.003_bib17","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1182\/blood.V77.9.1901.1901","article-title":"Hemostatic effect of normal platelet transfusion in severe von Willebrand disease patients","volume":"77","author":"Castillo","year":"1991","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.anclin.2026.04.003_bib18","article-title":"Postpartum hemorrhage and tranexamic acid: a literature review","volume":"15","author":"Anaposala","year":"2023","journal-title":"Cureus"},{"issue":"10","key":"10.1016\/j.anclin.2026.04.003_bib19","article-title":"Skewed inactivation of X chromosome: a cause of Hemophilia manifestation in carrier females","volume":"12","author":"Shoukat","year":"2020","journal-title":"Cureus"},{"issue":"7","key":"10.1016\/j.anclin.2026.04.003_bib20","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/MBC.0b013e3283566af9","article-title":"Impact of inherited bleeding disorders on pregnancy and postpartum hemorrhage","volume":"23","author":"Shahbazi","year":"2012","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"6","key":"10.1016\/j.anclin.2026.04.003_bib21","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1097\/AOG.0b013e3181c2bde8","article-title":"Pregnancy and laboratory studies: a reference table for clinicians","volume":"114","author":"Abbassi-Ghanavati","year":"2009","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.anclin.2026.04.003_bib22","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1365-2516.2007.01561.x","article-title":"Pregnancy in carriers of haemophilia","volume":"14","author":"Chi","year":"2008","journal-title":"Haemophilia"},{"issue":"2","key":"10.1016\/j.anclin.2026.04.003_bib23","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.hoc.2011.01.007","article-title":"Factor deficiencies in pregnancy","volume":"25","author":"Pike","year":"2011","journal-title":"Hematol Oncol Clin N Am"},{"key":"10.1016\/j.anclin.2026.04.003_bib24","unstructured":"MASAC guidelines for perinatal management of women with bleeding disorders and carriers of hemophilia A or B in MASAC document #251: Medical and Scientific Advisory Council of the National Hemophilia Foundation. The document was approved by the Medical and Scientific Advisory Council (MASAC) of the National Hemophilia Foundation (NHF) on August 26, 2017, and adopted by the NHF Board of Directors on September 17, 2017."},{"issue":"2","key":"10.1016\/j.anclin.2026.04.003_bib25","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1365-2516.2010.02426.x","article-title":"Association between phenotype and genotype in carriers of haemophilia A","volume":"17","author":"Miesbach","year":"2011","journal-title":"Haemophilia"},{"issue":"2","key":"10.1016\/j.anclin.2026.04.003_bib26","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/s00540-021-02911-1","article-title":"Delivery and neuraxial technique outcomes in patients with hemophilia and in hemophilia carriers: a systematic review","volume":"35","author":"Togioka","year":"2021","journal-title":"J Anesth"},{"issue":"Suppl 6","key":"10.1016\/j.anclin.2026.04.003_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/hae.14046","article-title":"WFH Guidelines for the Management of Hemophilia, 3rd edition","volume":"26","author":"Srivastava","year":"2020","journal-title":"Haemophilia"},{"issue":"12","key":"10.1016\/j.anclin.2026.04.003_bib28","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1111\/jth.12756","article-title":"Pharmacokinetic and pharmacodynamic properties of plasma-derived vs. recombinant factor IX in patients with hemophilia B: a prospective crossover study","volume":"12","author":"Alamelu","year":"2014","journal-title":"J Thromb Haemost"},{"issue":"Suppl 1","key":"10.1016\/j.anclin.2026.04.003_bib29","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/S0268-960X(15)30002-3","article-title":"Recombinant activated factor VII: 30 years of research and innovation","volume":"29","author":"Hedner","year":"2015","journal-title":"Blood Rev"},{"issue":"6","key":"10.1016\/j.anclin.2026.04.003_bib30","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1213\/ANE.0b013e3181c039e6","article-title":"Recombinant activated factor VII in obstetric hemorrhage: experiences from the Australian and New Zealand Haemostasis Registry","volume":"109","author":"Phillips","year":"2009","journal-title":"Anesth Analg"},{"issue":"1","key":"10.1016\/j.anclin.2026.04.003_bib31","doi-asserted-by":"crossref","DOI":"10.1080\/14767058.2024.2332794","article-title":"Role of recombinant factor VIIa in the clinical management of severe postpartum hemorrhage: consensus among European experts","volume":"37","author":"Surbek","year":"2024","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"4","key":"10.1016\/j.anclin.2026.04.003_bib32","doi-asserted-by":"crossref","first-page":"157","DOI":"10.4103\/1947-2714.94938","article-title":"Recombinant factor VIIa in post-partum hemorrhage: a new weapon in Obstetrician\u2019s armamentarium","volume":"4","author":"Magon","year":"2012","journal-title":"N Am J Med Sci"},{"issue":"5","key":"10.1016\/j.anclin.2026.04.003_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2024.102533","article-title":"Thromboembolic events in severe postpartum hemorrhage treated with recombinant activated factor VII: a systematic literature review and meta-analysis","volume":"8","author":"van der Bom","year":"2024","journal-title":"Res Pract Thromb Haemost"},{"issue":"1","key":"10.1016\/j.anclin.2026.04.003_bib34","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1182\/blood-2008-06-160432","article-title":"How we treat a hemophilia A patient with a factor VIII inhibitor","volume":"113","author":"Kempton","year":"2009","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.anclin.2026.04.003_bib36","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1365-2516.2006.01347.x","article-title":"Screening for factor XI deficiency amongst pregnant women of Ashkenazi Jewish origin","volume":"12","author":"Kadir","year":"2006","journal-title":"Haemophilia"},{"key":"10.1016\/j.anclin.2026.04.003_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijoa.2024.104289","article-title":"Moderate factor XI deficiency and neuraxial procedures in an obstetric cohort: a retrospective study (2014-2021)","volume":"61","author":"Billeret","year":"2025","journal-title":"Int J Obstet Anesth"},{"issue":"1","key":"10.1016\/j.anclin.2026.04.003_bib38","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1055\/s-0038-1645682","article-title":"The effect of combined factor XI deficiency with von Willebrand factor abnormalities on haemorrhagic diathesis","volume":"63","author":"Tavori","year":"1990","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.anclin.2026.04.003_bib39","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ejogrb.2017.06.008","article-title":"Management of parturients with factor XI deficiency-10year case series and review of literature","volume":"215","author":"Verghese","year":"2017","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"5","key":"10.1016\/j.anclin.2026.04.003_bib40","first-page":"512","article-title":"Factor XI deficiency in Iranians: its clinical manifestations in comparison with those of classic hemophilia","volume":"87","author":"Peyvandi","year":"2002","journal-title":"Haematologica"},{"issue":"7","key":"10.1016\/j.anclin.2026.04.003_bib41","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1080\/17474086.2020.1772745","article-title":"The clinical management of factor XI deficiency in pregnant women","volume":"13","author":"Wheeler","year":"2020","journal-title":"Expert Rev Hematol"},{"issue":"1","key":"10.1016\/j.anclin.2026.04.003_bib42","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1538-7836.2010.04120.x","article-title":"The role of thrombin activatable fibrinolysis inhibitor and factor XI in platelet-mediated fibrinolysis resistance: a thromboelastographic study in whole blood","volume":"9","author":"Carrieri","year":"2011","journal-title":"J Thromb Haemost"},{"issue":"8","key":"10.1016\/j.anclin.2026.04.003_bib43","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1182\/blood.V86.8.3035.3035","article-title":"Feedback activation of factor XI by thrombin in plasma results in additional formation of thrombin that protects fibrin clots from fibrinolysis","volume":"86","author":"von dem Borne","year":"1995","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.anclin.2026.04.003_bib44","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1111\/jth.13342","article-title":"Reduced fibrinolytic resistance in patients with factor XI deficiency. Evidence of a thrombin-independent impairment of the thrombin-activatable fibrinolysis inhibitor pathway","volume":"14","author":"Colucci","year":"2016","journal-title":"J Thromb Haemost"},{"issue":"2","key":"10.1016\/j.anclin.2026.04.003_bib45","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.thromres.2015.06.025","article-title":"The impact of thrombin generation and rotation thromboelastometry on assessment of severity of factor XI deficiency","volume":"136","author":"Livnat","year":"2015","journal-title":"Thromb Res"},{"key":"10.1016\/j.anclin.2026.04.003_bib46","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.cca.2021.10.021","article-title":"Evaluation of thrombin generation assay in factor XI deficiency","volume":"523","author":"Kasonga","year":"2021","journal-title":"Clin Chim Acta"},{"issue":"5","key":"10.1016\/j.anclin.2026.04.003_bib47","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1111\/j.1365-2516.2009.01984.x","article-title":"Pregnancy and rare bleeding disorders","volume":"15","author":"Kadir","year":"2009","journal-title":"Haemophilia"},{"issue":"3","key":"10.1016\/j.anclin.2026.04.003_bib48","first-page":"140","article-title":"Longitudinal evaluation of markers of hemostasis in pregnancy","volume":"115","author":"Hammerova","year":"2014","journal-title":"Bratisl Lek Listy"},{"issue":"5","key":"10.1016\/j.anclin.2026.04.003_bib49","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1471-0528.2007.01296.x","article-title":"Pregnancy outcome in factor XI deficiency: incidence of miscarriage, antenatal and postnatal haemorrhage in 33 women with factor XI deficiency","volume":"114","author":"Myers","year":"2007","journal-title":"BJOG"},{"issue":"20","key":"10.1016\/j.anclin.2026.04.003_bib50","doi-asserted-by":"crossref","first-page":"5025","DOI":"10.1182\/bloodadvances.2020002740","article-title":"Bleeding severity in patients with rare bleeding disorders: real-life data from the RBiN study","volume":"4","author":"Saes","year":"2020","journal-title":"Blood Adv"},{"issue":"10","key":"10.1016\/j.anclin.2026.04.003_bib51","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1182\/bloodadvances.2022008648","article-title":"Obstetric and perioperative management of patients with factor XI deficiency: a retrospective observational study","volume":"7","author":"Handa","year":"2023","journal-title":"Blood Adv"},{"issue":"3","key":"10.1016\/j.anclin.2026.04.003_bib52","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1471-0528.1998.tb10093.x","article-title":"Pregnancy in women with von Willebrand\u2019s disease or factor XI deficiency","volume":"105","author":"Kadir","year":"1998","journal-title":"Br J Obstet Gynaecol"},{"issue":"12","key":"10.1016\/j.anclin.2026.04.003_bib53","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1055\/s-0039-1696685","article-title":"Single low dose of rFVIIa combined with antifibrinolytic agent is a simple and safe treatment for factor XI-Deficient patients undergoing surgery","volume":"119","author":"Salomon","year":"2019","journal-title":"Thromb Haemost"},{"issue":"10","key":"10.1016\/j.anclin.2026.04.003_bib54","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1080\/00016340903144238","article-title":"The obstetric experience of women with factor XI deficiency","volume":"88","author":"Chi","year":"2009","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.anclin.2026.04.003_bib55","doi-asserted-by":"crossref","DOI":"10.1177\/1076029619880262","article-title":"Peri- and postpartum management of patients with factor XI deficiency","volume":"25","author":"Gerber","year":"2019","journal-title":"Clin Appl Thromb Hemost"},{"issue":"15","key":"10.1016\/j.anclin.2026.04.003_bib56","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1182\/blood.2023020721","article-title":"Factor XI deficiency: phenotypic age-related considerations and clinical approach towards bleeding risk assessment","volume":"143","author":"Barg","year":"2024","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.anclin.2026.04.003_bib57","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1111\/hae.14079","article-title":"Epidural\/spinal anesthesia during delivery in women with factor XI deficiency, a single center experience","volume":"26","author":"Shacham Abulafia","year":"2020","journal-title":"Haemophilia"},{"issue":"3","key":"10.1016\/j.anclin.2026.04.003_bib58","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1160\/TH10-12-0816","article-title":"Monitoring low dose recombinant factor VIIa therapy in patients with severe factor XI deficiency undergoing surgery","volume":"106","author":"Riddell","year":"2011","journal-title":"Thromb Haemost"},{"issue":"2","key":"10.1016\/j.anclin.2026.04.003_bib59","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/hae.12856","article-title":"Gynaecological and obstetrical bleeding in women with factor XI deficiency - a systematic review","volume":"22","author":"Wiewel-Verschueren","year":"2016","journal-title":"Haemophilia"},{"issue":"4","key":"10.1016\/j.anclin.2026.04.003_bib60","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/hae.12678","article-title":"Factor XI-related thrombosis and the role of concentrate treatment in factor XI deficiency","volume":"21","author":"Pike","year":"2015","journal-title":"Haemophilia"},{"issue":"4","key":"10.1016\/j.anclin.2026.04.003_bib61","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/hae.12682","article-title":"Ongoing risk of thrombosis with factor XI concentrate: 5 years experience in two centres","volume":"21","author":"Batty","year":"2015","journal-title":"Haemophilia"},{"issue":"12","key":"10.1016\/j.anclin.2026.04.003_bib62","doi-asserted-by":"crossref","first-page":"4783","DOI":"10.1182\/blood-2002-09-2794","article-title":"Prevalence, causes, and characterization of factor XI inhibitors in patients with inherited factor XI deficiency","volume":"101","author":"Salomon","year":"2003","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.anclin.2026.04.003_bib63","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1111\/hae.70052","article-title":"Recombinant activated factor VIIa combined with tranexamic acid control haemostasis in patients with severe factor XI deficiency undergoing urological procedures","volume":"31","author":"Sternbach","year":"2025","journal-title":"Haemophilia"},{"issue":"4","key":"10.1016\/j.anclin.2026.04.003_bib64","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/j.1365-2516.2008.01663.x","article-title":"Recombinant factor VIIa to prevent surgical bleeding in factor XI deficiency","volume":"14","author":"O'Connell","year":"2008","journal-title":"Haemophilia"},{"issue":"6","key":"10.1016\/j.anclin.2026.04.003_bib65","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1111\/j.1365-2516.2011.02525.x","article-title":"The role of recombinant factor VIIa for obstetric block in women with severe factor XI deficiency","volume":"17","author":"Setty","year":"2011","journal-title":"Haemophilia"},{"issue":"5","key":"10.1016\/j.anclin.2026.04.003_bib66","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1365-2516.2004.00944.x","article-title":"The rare coagulation disorders--review with guidelines for management from the United Kingdom Haemophilia Centre Doctors\u2019 Organisation","volume":"10","author":"Bolton-Maggs","year":"2004","journal-title":"Haemophilia"},{"issue":"3","key":"10.1016\/j.anclin.2026.04.003_bib67","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/bjh.13058","article-title":"Guideline for the diagnosis and management of the rare coagulation disorders: a United Kingdom Haemophilia Centre doctors\u2019 Organization guideline on behalf of the British Committee for Standards in Haematology","volume":"167","author":"Mumford","year":"2014","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1016\/j.anclin.2026.04.003_bib68","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1182\/blood-2004-02-0595","article-title":"Recessively inherited coagulation disorders","volume":"104","author":"Mannucci","year":"2004","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.anclin.2026.04.003_bib69","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1538-7836.2003.t01-1-00553.x","article-title":"Rare bleeding disorder registry: deficiencies of factors II, V, VII, X, XIII, fibrinogen and dysfibrinogenemias","volume":"2","author":"Acharya","year":"2004","journal-title":"J Thromb Haemost"},{"issue":"4","key":"10.1016\/j.anclin.2026.04.003_bib70","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1538-7836.2012.04653.x","article-title":"Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding Disorders","volume":"10","author":"Peyvandi","year":"2012","journal-title":"J Thromb Haemost"},{"issue":"4","key":"10.1016\/j.anclin.2026.04.003_bib71","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1365-2516.2006.01287.x","article-title":"Pregnancy in women with congenital factor VII deficiency","volume":"12","author":"Kulkarni","year":"2006","journal-title":"Haemophilia"},{"issue":"10","key":"10.1016\/j.anclin.2026.04.003_bib72","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/j.1471-0528.1994.tb13557.x","article-title":"Severe factor X deficiency and successful pregnancy","volume":"101","author":"Konje","year":"1994","journal-title":"Br J Obstet Gynaecol"},{"issue":"8","key":"10.1016\/j.anclin.2026.04.003_bib73","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/j.1471-0528.1976.tb00902.x","article-title":"A serial study of coagulation factors XII, XI and X in plasma in normal pregnancy and in pregnancy complicated by pre-eclampsia","volume":"83","author":"Condie","year":"1976","journal-title":"Br J Obstet Gynaecol"},{"issue":"6","key":"10.1016\/j.anclin.2026.04.003_bib74","doi-asserted-by":"crossref","first-page":"e349","DOI":"10.1111\/hae.12259","article-title":"Congenital factor XIII deficiency in women: a systematic review of literature","volume":"19","author":"Sharief","year":"2013","journal-title":"Haemophilia"},{"issue":"2","key":"10.1016\/j.anclin.2026.04.003_bib75","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/GRF.0000000000000787","article-title":"Maternal coagulation disorders and postpartum hemorrhage","volume":"66","author":"Bank","year":"2023","journal-title":"Clin Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.anclin.2026.04.003_bib76","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12491","article-title":"Evaluating hemostatic thresholds for neuraxial anesthesia in adults with hemorrhagic disorders and tendencies: a scoping review","volume":"5","author":"Peterson","year":"2021","journal-title":"Res Pract Thromb Haemost"},{"issue":"4","key":"10.1016\/j.anclin.2026.04.003_bib77","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/hae.14086","article-title":"Management of pregnancy in women with factor VII deficiency: a case series","volume":"26","author":"Lee","year":"2020","journal-title":"Haemophilia"},{"issue":"3","key":"10.1016\/j.anclin.2026.04.003_bib78","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/hae.12318","article-title":"Tranexamic acid as adjunct therapy to bypassing agents in haemophilia A patients with inhibitors","volume":"20","author":"Tran","year":"2014","journal-title":"Haemophilia"},{"issue":"6","key":"10.1016\/j.anclin.2026.04.003_bib79","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/ejh.13941","article-title":"Management of rare inherited bleeding disorders: proposals of the French reference centre on haemophilia and rare coagulation disorders","volume":"110","author":"Trossaert","year":"2023","journal-title":"Eur J Haematol"},{"issue":"5","key":"10.1016\/j.anclin.2026.04.003_bib80","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.transci.2019.08.006","article-title":"An overview of inherited factor VII deficiency","volume":"58","author":"Robinson","year":"2019","journal-title":"Transfus Apher Sci"}],"container-title":["Anesthesiology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1932227526000467?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1932227526000467?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T19:32:17Z","timestamp":1785439937000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1932227526000467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":79,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1932227526000467"],"URL":"https:\/\/doi.org\/10.1016\/j.anclin.2026.04.003","relation":{},"ISSN":["1932-2275"],"issn-type":[{"value":"1932-2275","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anesthetic and Peripartum Management of Inherited Coagulation Disorders in Pregnancy","name":"articletitle","label":"Article Title"},{"value":"Anesthesiology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anclin.2026.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}